|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Selling, general and administrative | |||||
| Restructuring and other charges | |||||
| Talcum litigation settlement agreements | |||||
| Securities Class Action | |||||
| Talcum Litigation | |||||
| Total talcum litigation settlement agreements | |||||
| Goodwill impairment | |||||
| Impairment of other intangible assets | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Interest expense | |||||
| Interest income and investment income, net | |||||
| Other components of net periodic benefit cost | |||||
| Other income, net | |||||
| Earnings (loss) before income taxes | |||||
| Provision for income taxes | |||||
| Net earnings (loss) | |||||
| Net earnings attributable to noncontrolling interests | |||||
| Net earnings attributable to redeemable noncontrolling interest | |||||
| Net earnings (loss) attributable to The Estée Lauder Companies Inc. | |||||
| Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...